{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:25Z","timestamp":1786985785651,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002949","name":"Jiangsu Province","doi-asserted-by":"publisher","award":["BE2015611"],"award-info":[{"award-number":["BE2015611"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Jiangsu Province","doi-asserted-by":"publisher","award":["H201341"],"award-info":[{"award-number":["H201341"]}],"id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.cca.2017.05.007","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T11:18:09Z","timestamp":1494328689000},"page":"109-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["HE4 expression in lung cancer, a meta-analysis"],"prefix":"10.1016","volume":"470","author":[{"given":"Hai","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linfei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cca.2017.05.007_bb0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cca.2017.05.007_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"issue":"11","key":"10.1016\/j.cca.2017.05.007_bb0015","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/clinchem\/48.11.1931","article-title":"Carcinoembryonic antigen, squamous cell carcinoma antigen, CYFRA 21-1, and neuron-specific enolase in squamous cell lung cancer patients","volume":"48","author":"Kulpa","year":"2002","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.cca.2017.05.007_bb0020","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1373\/clinchem.2008.105494","article-title":"National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines for the use of tumor markers","volume":"54","author":"Diamandis","year":"2008","journal-title":"Clin. Chem."},{"issue":"7","key":"10.1016\/j.cca.2017.05.007_bb0025","doi-asserted-by":"crossref","first-page":"6847","DOI":"10.1007\/s13277-014-1943-8","article-title":"Evaluating the expression and diagnostic value of human epididymis protein 4 (HE4) in small cell lung cancer","volume":"35","author":"Wang","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2017.05.007_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-405211-6.00001-2","article-title":"Human epididymis protein 4 in cancer diagnostics: a promising and reliable tumor marker","volume":"59","author":"Speeckaert","year":"2013","journal-title":"Adv. Clin. Chem."},{"issue":"5","key":"10.1016\/j.cca.2017.05.007_bb0035","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/IGC.0b013e31821a3726","article-title":"Human epididymis protein 4 (HE4) as a serum tumor biomarker in patients with ovarian carcinoma","volume":"21","author":"Chang","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"3","key":"10.1016\/j.cca.2017.05.007_bb0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1517\/17530059.2011.559459","article-title":"fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma","volume":"5","author":"Hellstrom","year":"2011","journal-title":"Expert Opin. Med. Diagn."},{"issue":"11","key":"10.1016\/j.cca.2017.05.007_bb0045","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/1055-9965.EPI-14-0447","article-title":"HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review","volume":"23","author":"Karlsen","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"10.1016\/j.cca.2017.05.007_bb0050","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1007\/s13277-012-0499-8","article-title":"Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression","volume":"33","author":"Yamashita","year":"2012","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.cca.2017.05.007_bb0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ygyno.2013.07.094","article-title":"Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer","volume":"131","author":"Kristjansdottir","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.cca.2017.05.007_bb0060","first-page":"4779","article-title":"HE4 expression can be associated with lymph node metastases and disease-free survival in breast cancer","volume":"30","author":"Kamei","year":"2010","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.cca.2017.05.007_bb0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s12094-015-1375-y","article-title":"Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer","volume":"18","author":"Lan","year":"2016","journal-title":"Clin. Transl. Oncol."},{"issue":"6","key":"10.1016\/j.cca.2017.05.007_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128836","article-title":"Serum HE4: an independent prognostic factor in non-small cell lung cancer","volume":"10","author":"Lamy","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cca.2017.05.007_bb0075","first-page":"5568","article-title":"Expression level of serum human epididymis 4 and its prognostic significance in human non-small cell lung cancer","volume":"7","author":"Jiang","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"10","key":"10.1016\/j.cca.2017.05.007_bb0080","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.5588\/ijtld.13.0058","article-title":"Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis","volume":"17","author":"Liu","year":"2013","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"2","key":"10.1016\/j.cca.2017.05.007_bb0085","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s13277-010-0118-5","article-title":"Prognostic significance of HE4 expression in pulmonary adenocarcinoma","volume":"32","author":"Yamashita","year":"2011","journal-title":"Tumour Biol."},{"issue":"4","key":"10.1016\/j.cca.2017.05.007_bb0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/CBM-140399","article-title":"Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancer","volume":"14","author":"Lou","year":"2014","journal-title":"Cancer Biomark."},{"issue":"11","key":"10.1016\/j.cca.2017.05.007_bb0095","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1515\/cclm-2014-0041","article-title":"Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer","volume":"52","author":"Nagy","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"issue":"4","key":"10.1016\/j.cca.2017.05.007_bb0100","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s13277-012-0356-9","article-title":"Serum HE4 as a diagnostic and prognostic marker for lung cancer","volume":"33","author":"Iwahori","year":"2012","journal-title":"Tumour Biol."},{"issue":"6","key":"10.1016\/j.cca.2017.05.007_bb0105","first-page":"423","article-title":"The prognostic value of serum HE4 in lung cancer [article in Chinese]","volume":"34","author":"Zhang","year":"2014","journal-title":"Chin. J. Radiol. Med. Prot."},{"issue":"9","key":"10.1016\/j.cca.2017.05.007_bb0110","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.cca.2017.05.007_bb0115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/0962280210392008","article-title":"Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: a simulation study","volume":"21","author":"Kontopantelis","year":"2012","journal-title":"Stat. Methods Med. Res."},{"issue":"6","key":"10.1016\/j.cca.2017.05.007_bb0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/sim.650","article-title":"A comparison of statistical methods for meta-analysis","volume":"20","author":"Brockwell","year":"2001","journal-title":"Stat. Med."},{"issue":"7109","key":"10.1016\/j.cca.2017.05.007_bb0125","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.cca.2017.05.007_bb0130","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"issue":"24","key":"10.1016\/j.cca.2017.05.007_bb0135","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Stat. Med."},{"key":"10.1016\/j.cca.2017.05.007_bb0140","doi-asserted-by":"crossref","first-page":"eS56","DOI":"10.3949\/ccjm.79.s2.12","article-title":"Personalized targeted therapy in advanced non-small cell lung cancer","volume":"79","author":"Ma","year":"2012","journal-title":"Cleve. Clin. J. Med."},{"issue":"6","key":"10.1016\/j.cca.2017.05.007_bb0145","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.cca.2017.05.007_bb0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.cca.2017.05.007_bb0155","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ygyno.2012.11.023","article-title":"Preoperative HE4 expression in plasma predicts surgical outcome in primary ovarian cancer patients: results from the OVCAD study","volume":"128","author":"Braicu","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"9","key":"10.1016\/j.cca.2017.05.007_bb0160","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/bjc.2011.109","article-title":"Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients","volume":"104","author":"Bignotti","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.cca.2017.05.007_bb0165","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s13277-014-2858-0","article-title":"The human epididymis protein 4 acts as a prognostic factor and promotes progression of gastric cancer","volume":"36","author":"Guo","year":"2015","journal-title":"Tumour Biol."},{"issue":"17","key":"10.1016\/j.cca.2017.05.007_bb0170","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1038\/sj.onc.1205363","article-title":"The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms","volume":"21","author":"Bingle","year":"2002","journal-title":"Oncogene"},{"issue":"25","key":"10.1016\/j.cca.2017.05.007_bb0175","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1016\/S0021-9258(18)77182-2","article-title":"Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence","volume":"265","author":"Wiedow","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.cca.2017.05.007_bb0180","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1073\/pnas.83.18.6692","article-title":"Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase","volume":"83","author":"Thompson","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.cca.2017.05.007_bb0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s13277-011-0256-4","article-title":"Human epididymis protein 4 reference limits and natural variation in a Nordic reference population","volume":"33","author":"Bolstad","year":"2012","journal-title":"Tumour Biol."},{"issue":"Pt 4","key":"10.1016\/j.cca.2017.05.007_bb0190","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1258\/acb.2011.011258","article-title":"Elevated human epididymis protein 4 concentrations in chronic kidney disease","volume":"49","author":"Nagy","year":"2012","journal-title":"Ann. Clin. Biochem."},{"issue":"3","key":"10.1016\/j.cca.2017.05.007_bb0195","doi-asserted-by":"crossref","first-page":"6026","DOI":"10.3390\/ijms14036026","article-title":"HE4 (WFDC2) promotes tumor growth in endometrial cancer cell lines","volume":"14","author":"Li","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cca.2017.05.007_bb0200","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1177\/147323001103900507","article-title":"The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis","volume":"39","author":"Gao","year":"2011","journal-title":"J. Int. Med. Res."},{"issue":"12","key":"10.1016\/j.cca.2017.05.007_bb0205","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-11-0635","article-title":"Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management","volume":"20","author":"Bandiera","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.cca.2017.05.007_bb0210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cca.2016.02.002","article-title":"Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer","volume":"455","author":"Zeng","year":"2016","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2017.05.007_bb0215","doi-asserted-by":"crossref","first-page":"352670","DOI":"10.1155\/2015\/352670","article-title":"The diagnostic accuracy of HE4 in lung cancer: a meta-analysis","volume":"2015","author":"Cheng","year":"2015","journal-title":"Dis. Markers"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117301717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117301717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T07:02:16Z","timestamp":1658991736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117301717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":43,"alternative-id":["S0009898117301717"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.05.007","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HE4 expression in lung cancer, a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}